| Application no. and date | 00953283.9 (espacenet) (Federated) (European Patent Register), 20000804 | | Patent/reg. no. and date | DK/EP 1223918, 20030205 | | Publication date | 20020724 | | Priority no. and date | GB 0001621, 20000126 | | EP pub. no. and date |
EP 1223918 20020724 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | CREEKMORE, Joseph, Richard, 1800 Concord Pike
Wilmington, DE 19850-5437, US,
WIGGINS, Norman, Alfred, 1800 Concord Pike
Wilmington, DE 19850-5437, US | | Representative | | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61K 9/20 (2006.01) | | Title | Farmaceutiske præparater omfattende en HMG-CoA-reductaseinhibitor | | Int. application no. | GB2000003014 | | Int. publication no. | WO2001054668 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
